Molecular targets for green tea in prostate cancer prevention

Journal of Nutrition

Volumn 133, Issue 7 SUPPL., 2003, Pages

  Adhami, Vaqar M ^a   Ahmad, Nihal ^a   Mukhtar, Hasan ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Apoptosis; Cell cycle; Chemoprevention; Green tea; Metalloproteinases; Prostate cancer

Indexed keywords

ANDROGEN; EPIGALLOCATECHIN GALLATE; GELATINASE A; GELATINASE B; GUANINE NUCLEOTIDE BINDING PROTEIN; ORNITHINE DECARBOXYLASE; POLYPHENOL; PROTEASOME; PROTEIN P21;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER INHIBITION; CANCER MORTALITY; CANCER PREVENTION; CHINA; CONFERENCE PAPER; CONTROLLED STUDY; DNA MICROARRAY; HUMAN; HUMAN CELL; JAPAN; MALE; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; RAT; TEA; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0038000122     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.7.2417s     Document Type: Conference Paper

References (81)

1. Greenlee, R. T., Hill-Harmon, M. B., Murray, T. & Thun, M. (2001) Cancer statistics. CA Cancer J. Clin. 51: 15-36.
2. American Cancer Society (2002) Cancer Facts and Figures. Available on the Internet at http://www.cancer.org/downloads/STT/CancerFacts&Figures2002TM.pdf.
3. Mukhtar, H. & Ahmad, N. (1999) Cancer chemoprevention: future holds in multiple agents: contemporary issues in toxicology. Toxicol. Appl. Pharmacol. 158: 207-210.
4. Katiyar, S. K. & Mukhtar, H. (1996) Tea in chemoprevention of cancer: epidemiological and experimental studies. Int. J. Oncol. 8: 221-238.
5. Kelloff, G. J., Lieberman, R., Steele, V. E., Boone, C. W., Lubet, R. A., Kopelovitch, L., Malone, W. A., Crowell, J. A. & Sigman, C. C. (1999) Chemoprevention of prostate cancer: concepts and strategies. Eur. Urol. 35: 342-350.
6. Mukhtar, H. & Ahmad, N. (1999) Green tea in chemoprevention of cancer. Toxicol. Sci. 52(suppl. 2): 111-117.
7. Ahmad, N. & Mukhtar, H. (1999) Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr. Rev. 57: 78-83.
8. Kelloff, G. J., Crowell, J. A., Steele, V. E., Lubet, R. A., Boone, C. W., Malone, W. A., Hawk, E. T., Lieberman, R., Lawrence, J. A., Kopelovich, L., Ali, I., Viner, J. L. & Sigman, C. C. (1999) Progress in cancer chemoprevention. Ann. N. Y. Acad. Sci. 889: 1-13.
9. Weisburger, J. H. (1999) Tea and health: the underlying mechanisms. Proc. Soc. Exp. Biol. Med. 220: 271-275.
10. Yang, C. S. & Wang, Z. Y. (1993) Tea and cancer. J. Natl. Cancer Inst. 85: 1038-1049.
11. Mukhtar, H., Katiyar, S. K. & Agarwal, R. (1992) Green tea and skin anticarcinogenic effects. J. Invest. Dermatol. 18: 3-7.
12. Katiyar, S. K., Agarwal, R. & Mukhtar, H. (1993) Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea. Cancer Res. 53: 5409-5412.
13. Katiyar, S. K., Agarwal, R. & Mukhtar, H. (1993) Inhibition of both stage I and stage II skin tumor promotion in SENCAR mice by a polyphenotic fraction isolated from green tea: inhibition depends on the duration of polyphenol treatment. Carcinogenesis 14: 2641-2643.
14. Khan, S. G., Katiyar, S. K., Agarwal, R. & Mukhtar, H. (1992) Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res. 52: 4050-4052.
15. Gensler, H. L., Timmermann, B. N., Valcic, S., Wachter, G. A., Dorr, R., Dvorakova, K. & Alberts, D. S. (1996) Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea. Nutr. Cancer 26: 325-335.
16. Record, I. R. & Dreosti, I. E. (1998) Protection by tea against UV-A + B-induced skin cancers in hairless mice. Nutr. Cancer 32: 71-75.
17. Wang, Z. Y., Huang, M. T., Ho, C. T., Chang, R., Ma, W., Ferraro, T., Reuhl, K. R., Yang, C. S. & Conney, A. H. (1992) Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res. 52: 6657-6665.
18. Ahmad, N., Feyes, D. K., Nieminen, A. L., Agarwal, R. & Mukhtar, H. (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 89: 1881-1886.
19. Ahmad, N., Gupta, S. & Mukhtar, H. (2000) Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially modulates nuclear factor kappa B (NF-κB) in cancer cells vs. normal cells. Arch. Biochem. Biophys. 376: 338-346.
20. Chen, Z. P., Schell, J. B., Ho, C. T. & Chen, K. Y. (1998) Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett. 129: 173-179.
21. Xu, Y., Ho, C. T., Amin, S. G., Han, C. & Chung, F. L. (1992) Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and major polyphenol as antioxidants. Cancer Res. 52: 3875-3879.
22. Ahmad, N., Feyes, D. K., Nieminen, A. L., Agarwal, R. & Mukhtar, H. (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 89: 1881-1886.
23. Gupta, S., Ahmad, N., Nieminen, A. L. & Mukhtar, H. (2000) Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol. Appl. Pharmacol. 164: 82-90.
24. Setiawan, V. W., Zhang, Z. F., Yu, G. P., Lu, Q. Y., Li, Y. L., Lu, M. L., Wang, M. R., Guo, C. H., Yu, S. Z., Kurtz, R. C. & Hsieh, C. C. (2001) Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int. J. Cancer 92: 600-604.
25. Inoue, M., Tajima, K., Mizutani, M., Iwata, H., Iwase, T., Miura, S., Hirose, K., Hamajima, N. & Tominaga, S. (2001) Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-Based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett. 167: 175-182.
26. Gupta, S., Hastak, K., Ahmad, N., Lewin, J. S. & Mukhtar, H. (2001) Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. U S A 98: 10350-10355.
27. Gupta, S. & Mukhtar, H. (2002) Green tea and prostate cancer. Urol. Clin. North Am. 29: 49-57.
28. Gupta, S., Ahmad, N. & Mukhtar, H. (1999) Prostate cancer chemoprevention by green tea. Semin. Urol. Oncol. 17: 70-76.
29. Muir, C., Waterhouse, J., Mack, T., Powell, J. & Whelan, S. (1987) Cancer Incidence in Five Continents, vol. V, IARC Scientific Publications no. 88. International Agency for Research on Cancer, Lyon, France.
30. Heilbrun, L. K., Nomura, A. & Stemmermann, G. N. (1986) Black tea consumption and cancer risk: a prospective study. Br. J. Cancer 54: 677-683.
31. Jain, M. G., Hislop, G. T., Howe, G. R., Burch, J. D. & Ghadirian, P. (1998) Alcohol and other beverage use and prostate cancer risk among Canadian men. Int. J. Cancer 78: 707-711.
32. Wilding, G. (1995) Endocrine control of prostate cancer. Cancer Surv. 23: 43-62.
33. Huggins, C. & Hodges, C. V. (1972) Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J. Clin. 22: 232-240.
34. Lu, S., Tsai, S. Y. & Tsai, M. J. (1997) Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4 and CKIp16 genes. Cancer Res. 57: 4511-4516.
35. Ahmad, N., Feyes, D. K., Nieminen, A. L., Agarwal, R. & Mukhtar, H. (1997) Green tea constituent epigallocatech in-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 89: 1881-1886.
36. Chung, L. Y., Cheung, T. C., Kong, S. K., Fung, K. P., Choy, Y. M., Chan, Z. Y. & Kwok, T. T. (2001) Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci. 68: 1207-1214.
37. Paschka, A. G., Butler, R. & Young, C. Y. (1998) Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett. 130: 1-7.
38. Gupta, S., Ahmad, N., Nieminen, A. L. & Mukhtar, H. (2000) Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol. Appl. Pharmacol. 164: 82-90.
39. Danzin, C., Jung, M. J., Grove, J. & Bey, P. (1979) Effect of α-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on polyamine levels in rat tissues. Life Sci. 24: 519-524.
40. Betts, A. M., Waite, I., Neal, D. E. & Robson, C. N. (1997) Androgen regulation of ornithine decarboxylase in human prostatic cells identified using differential display. FEBS Lett. 405: 328-332.
41. Groll, M., Ditzel, L., Lowe, J., Stock, D., Bochtler, M., Bartunik, H. D. & Huber, R. (1997) Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386: 463-471.
42. Maupin-Fudow, J. A. & Ferry, J. G. (1995) A proteasome from the methanogenic archaeon Methanosarcina thermophila. J. Biol. Chem. 270: 28617-28622.
43. Goldberg, A. L. (1995) Functions of the proteasome: the lysis at the end of the tunnel. Science 268: 522-523.
44. Baumeister, W., Walz, J., Zuhl, F. & Seemuller, E. (1998) The proteasome: paradigm of a self-compartmentalizing protease. Cell 92: 367-380.
45. Heinemeyer, W., Fischer, M., Krimmer, T., Stachon, U. & Wolf, D. H. (1997) J. Biol. Chem. 272: 25200-25209.
46. Loidl, G., Groll, M., Musiol, H. J., Huber, R. & Moroder, L. (1999) Bivalency as a principle for proteasome inhibition. Proc. Natl. Acad. Sci. U.S.A. 96: 5418-5422.
47. Hochstrasser, M. (1995) Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol. 7: 215-223.
48. Dou, Q. P. & Li, B. (1999) Proteasome inhibitors as potential novel anticancer agents. Drug Resistance Updates 2: 215-223.
49. An, B., Goldfarb, R. H., Siman, R. & Dou, Q. P. (1998) Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell Death Differ. 5: 1062-1075.
50. Lopes, U. G., Erhardt, P., Yao, R. & Cooper, G. M. (1997) p53-Dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272: 12893-12896.
51. Nam, S., Smith, D. M. & Dou, Q. P. (2001) Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276: 13322-13330.
52. Wang, S. I. & Mukhtar, H. (2002) Gene expression profile in human pro-state LNCaP cancer cells by (-) epigallocatechin-3-gallate. Cancer Lett. 182: 43-51.
53. Livneh, E. & Fishman, D. D. (1997) Linking protein kinase C to cell-cycle control. Eur. J. Biochem. 248: 1-9.
54. Fishman, D. D., Segal, S. & Livneh, E. (1998) The role of protein kinase C in G1 and G2/M phases of the cell cycle. Int. J. Oncol. 12: 181-186.
55. Panagopoulos, I., Pandis, N., Thelin, S., Petersson, C., Mertens, F., Borg, A., Kristoffersson, U., Mitelman, F. & Aman, P. (1996) The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. Cancer Res. 56: 4871-4875.
56. Wary, K. K., Lou, Z., Buchberg, A. M., Siracusa, L. D., Druck, T., LaForgia, S. & Huebner, K. (1993) A homozygous deletion within the carbonic anhydrase-like domain of the Ptprg gene in murine L-cells. Cancer Res. 53: 1498-1502.
57. Zhang, X. Q., Lee, M. S., Zelivianski, S. & Lin, M. F. (2001) Characterization of a prostate-specific tyrosine phosphatase by mutagenesis and expression in human prostate cancer cells. J. Biol. Chem. 276: 2544-2550.
58. Maxwell, S. A. & Davis, G. E. (2000) Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc. Natl. Acad. Sci. U.S.A. 97: 13009-13014.
59. Kaplan, D. R. & Miller, F. D. (2000) Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10: 381-391.
60. Gupta, S., Ahmad, N., Mohan, R. R., Husain, M. M. & Mukhtar, H. (1999) Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res. 59: 2115-2120.
61. Liao, S., Umekita, Y., Guo, J., Kokontis, J. M. & Hiipakka, R. A. (1995) Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 96: 239-243.
62. Liao, S. & Hiipakka, R. A. (1995) Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem. Biophys. Res. Commun. 214: 833-838.
63. Hiipakka, R. A., Zhang, H. Z., Dai, W., Dai, Q. & Liao, S. (2002) Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols. Biochem. Pharmacol. 63: 1165-1176.
64. Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J. & Rosen, J. M. (1995) Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. U.S.A. 92: 3439-3443.
65. Yu, H. & Rohan, T. (2000) Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 92: 1472-1489.
66. Egelbad, M. & Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2: 161-174.
67. O-charoenrat, P., Rhys-Evans, P. & Eccles, S. (2002) A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops. Int. J. Cancer 100: 527-533.
68. Coussens, L. M., Fingleton, B. & Matrisian, L. M. (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392.
69. Cao, Y., Cao, R. & Brakenhielm, E. (2002) Antiangiogenic mechanisms of diet-dedved olyphenols. J. Nutr. Biochem. 13: 380-390.
70. Singh, A. K., Seth, P., Anthony, P., Husain, M. M., Madhavan, S., Mukhtar, H. & Maheshwari, R. K. (2002) Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells. Arch. Biochem. Biophys. 401: 29-37.
71. Jung, Y. D. & Ellis, L. M. (2001) Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int. J. Exp. Pathol. 82: 309-316.
72. Garbisa, S., Sartor, L., Biggin, S., Salvato, B., Benelli, R. & Albini, A. (2001) Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91: 822-832.
73. Sartippour, M. R., Shao, Z. M., Heber, D., Beatty, P., Zhang, L., Liu, C., Ellis, L., Liu, W. & Go, V. L. (2002) Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J. Nutr. 132: 2307-2311.
74. Jung, Y. D., Kim, M. S., Shin, B. A., Chay, K. O., Ahn, B. W., Liu, W., Bucana, C. D., Gallick, G. E. & Ellis, L. M. (2001) EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br. J. Cancer 84: 844-850.
75. Garbisa, S., Sartor, L., Biggin, S., Salvato, B., Benelli, R. & Albini, A. (2001) Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91: 822-832.
76. Jankun, J., Selman, S. H., Swiercz, R. & Skrzypczak-Jankun, E. (1997) Why drinking green tea could prevent cancer. Nature 387: 561.
77. Daniel, C., Duffield, J., Brunner, T., Steinmann-Niggli, K., Lods, N. & Marti, H. P. (2001) Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells. J. Pharmacol. Exp. Ther. 297: 57-68.
78. La Vecchia, C., Negri, E., Franceschi, S., D'Avanzo, B. & Boyle, P. (1992) Tea consumption and cancer risk. Nutr. Cancer 17: 27-31.
79. Slattery, M. L. & West, D. W. (1993) Smoking, alcohol, coffee, tea, caffeine, and theobromine: risk of prostate cancer in Utah (United States). Cancer Causes Control 4: 559-563.
80. Ellison, L. F. (2000) Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study. Eur. J. Cancer Prev. 9: 125-130.
81. Jatoi, A., Dakhil, P. B., Mattar, B., Sloan, J., Fitch, T., Novotny, P., Camodano, J., Young, C., Rowland, K., Quevedo, F. & Tan, W. (2002) A phase II trial of green tea for androgen-independent prostate cancer: a north central cancer treatment group (NCCTG) trial. Proc. of the 93rd Annual Meeting of the American Association for Cancer Research 43: 492 (Abs.).